位置:首页 > 蛋白库 > LATA_STEGR
LATA_STEGR
ID   LATA_STEGR              Reviewed;        1400 AA.
AC   L7X8P2;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 1.
DT   03-AUG-2022, entry version 33.
DE   RecName: Full=Alpha-latrotoxin-Sg1a {ECO:0000305};
DE            Short=Alpha-LTX-Sg1a {ECO:0000305};
DE   AltName: Full=Alpha-latrotoxin {ECO:0000303|PubMed:23339183};
DE            Short=Alpha-LTX {ECO:0000303|PubMed:23339183};
DE   Flags: Precursor;
OS   Steatoda grossa (False black widow).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC   Araneomorphae; Entelegynae; Araneoidea; Theridiidae; Steatoda.
OX   NCBI_TaxID=256750;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=23339183; DOI=10.1093/molbev/mst011;
RA   Garb J.E., Hayashi C.Y.;
RT   "Molecular evolution of alpha-latrotoxin, the exceptionally potent
RT   vertebrate neurotoxin in black widow spider venom.";
RL   Mol. Biol. Evol. 30:999-1014(2013).
CC   -!- FUNCTION: Presynaptic neurotoxin that causes massive release of
CC       neurotransmitters from vertebrate (but not invertebrate) nerve
CC       terminals and endocrine cells via a complex mechanism involving
CC       activation of receptor(s) and toxin insertion into the plasma membrane
CC       with subsequent pore formation. Binds to neurexin-1-alpha (NRXN1) in a
CC       calcium dependent manner, adhesion G protein-coupled receptor L1
CC       (ADGRL1, also termed latrophilin-1 and calcium-independent receptor of
CC       latrotoxin (CIRL)), and receptor-type tyrosine-protein phosphatase S
CC       (PTPRS), also termed PTP sigma. NRXN1 and PTPRS are suggested to
CC       provide a platform for binding and subsequent pore formation events. In
CC       contrast, binding to ADGRL1 does not involve oligomerization and
CC       channel formation, but direct downstream stimulation of the synaptic
CC       fusion machinery. {ECO:0000250|UniProtKB:P23631}.
CC   -!- SUBUNIT: Homotetramer in membranes. {ECO:0000250|UniProtKB:P23631}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P23631}. Target
CC       cell membrane {ECO:0000250|UniProtKB:P23631}. Note=Forms a membrane
CC       channel in the prey. {ECO:0000250|UniProtKB:P23631}.
CC   -!- TISSUE SPECIFICITY: Expressed in venom gland, cephalothorax, and
CC       abdomen tissues from both males and females.
CC       {ECO:0000250|UniProtKB:P0DJE4}.
CC   -!- DOMAIN: The H8 helix is predicted to insert into membranes and form
CC       pores by assembling into tetramers. The helix is contained within a
CC       helical bundle domain that undergoes significant conformational changes
CC       during pore formation to allow exposure of the H8 transmembrane helix
CC       and transition of the toxin from a soluble monomer to a transmembrane
CC       tetramer. {ECO:0000250|UniProtKB:Q9XZC0}.
CC   -!- PTM: Processed by furin-like proteases at both the N- and C-termini.
CC   -!- MISCELLANEOUS: Is the main neurotoxin responsible for the human
CC       envenomation syndrome known as latrodectism that results from bites by
CC       Latrodectus species.
CC   -!- SIMILARITY: Belongs to the cationic peptide 01 (latrotoxin) family. 03
CC       (alpha-latrotoxin) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KC414039; AGD80173.1; -; Genomic_DNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.20; -; 4.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   Pfam; PF00023; Ank; 2.
DR   Pfam; PF12796; Ank_2; 5.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF13857; Ank_5; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 19.
DR   SUPFAM; SSF48403; SSF48403; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 11.
DR   PROSITE; PS50088; ANK_REPEAT; 13.
PE   3: Inferred from homology;
KW   ANK repeat; Exocytosis; Membrane; Neurotoxin; Presynaptic neurotoxin;
KW   Repeat; Secreted; Signal; Target cell membrane; Target membrane; Toxin.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000250|UniProtKB:P23631"
FT   CHAIN           21..1197
FT                   /note="Alpha-latrotoxin-Sg1a"
FT                   /id="PRO_0000455432"
FT   PROPEP          1198..1400
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000455433"
FT   REPEAT          490..520
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          524..553
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          558..588
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          592..621
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          625..655
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          659..689
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          694..726
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          728..757
FT                   /note="ANK 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          761..790
FT                   /note="ANK 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          794..823
FT                   /note="ANK 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          827..856
FT                   /note="ANK 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          861..890
FT                   /note="ANK 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          894..923
FT                   /note="ANK 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          927..957
FT                   /note="ANK 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          969..1001
FT                   /note="ANK 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1002..1031
FT                   /note="ANK 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1033..1062
FT                   /note="ANK 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1066..1095
FT                   /note="ANK 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1099..1129
FT                   /note="ANK 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1135..1164
FT                   /note="ANK 20"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1168..1197
FT                   /note="ANK 21"
FT                   /evidence="ECO:0000255"
FT   REGION          17..20
FT                   /note="Furin-like endopeptidase recognition region"
FT                   /evidence="ECO:0000250|UniProtKB:P23631"
FT   REGION          238..257
FT                   /note="Helix H8 is the probable transmembrane region of the
FT                   tetrameric pore inserted in the target cell membrane"
FT                   /evidence="ECO:0000250|UniProtKB:Q9XZC0"
FT   REGION          1194..1197
FT                   /note="Furin-like endopeptidase recognition region"
FT                   /evidence="ECO:0000250|UniProtKB:P23631"
SQ   SEQUENCE   1400 AA;  156398 MW;  941B23DF7F54C918 CRC64;
     MSAVEEIYQY TMNSSARLKR EDVELSLEEK AEICSELELQ QKSTDIAANI IGDISSLPIV
     GKIVGTMAAA MMAIAHVGSG ALDIQQTLLG CSDLPFDEIK EIMEQKFNEI DRKLDSHSKA
     LEEITKLAEK TLSSVEKTRK QMNKRFDEVL ESIKNTNIAP IVSKISNFGR YFDXEAERIR
     GLNLNDYVAK LEEEKGILYY LRESRTPKGD GLHAPLLIII NEGYAIPASI NDELAFKALD
     ALLYGTQTYV SVMFFLLEQY SFLANYYYGK GELDIYNKYF DSITNIFLDF KSSLVGSGGS
     DSAALLESVL QVLVAVKSKE FLKFLEMDVV VMLNEKISLF SKIKEDVDGK ERITSSLTPE
     NYVHISFEKD IPTPFGDWKE DKEVRYAVQY ESETLFSKVS HWSNPITVRG KACPTLRMPV
     DQNRKSILVF RKFENRKPQL VGSVSPYQSN FIDIDRDLYN AAGNPDLDVG HXEVVKLVAN
     GANIKAPFEQ GRTALHAAAE SGNAKVMFGL VLXSLGDLNK PDKNGFTAIH AAADKGNAGI
     VNLLIDYSAS VNVKTYRTLQ TPLHLAARRG FKRTFDRLLE SPDININEKD KDGFTPLHSA
     VLGGKEIVKA FINQPGTDIN AKSEKGLTPF HLAIINDDWP VAETLLTSES LQVNANDENN
     NTPLHYAVML GHLEIMKKLI NLSQVNVNAV SIPNLWSALH YAIFFKRDDV TLELLKILKV
     DKDLQSLGGI TPLHLAVSLG RKTVVSEMVR IGINLEQKTT EDFTPLHLAA MSKYPEIVTF
     LIDQGSNMEA KTANGATPLL LATLKGREQA SMILLGNEVN FRAVDKDGQM PIHGAAMNGM
     LEIAREIINL EPSIVAAQNN NLDTPLNLAA QHLHPEMVKF LVGRKADINT KNKDGNAPLL
     AFSKMGNLDM IKFLISNGAD VYIADNDGLN FFYYAVRHGH LNIIKYAMSE RKFTWSTPDN
     NRRRECPNEE CAISHFAVCD AIQYGKINVV KYFVGTLQHF SICRPLITAA MYGQLDIVKY
     LVEEEELNVN VAKPGTPLCH AAENGYLDVV KYLVENGXEI NRDCVRGETA IDMAISKNHI
     NVVRYLVKKG ADLRRRNALG STPFFTAVSS NSLDIARYFI NEKIGDIDIN EQNEKGESAL
     HLAVYYRNLQ MVKLLVENGI NVGIRNAIGK TALEIARDAR FSRIVEYLNT KSRRFRKGFQ
     ILRNAQGYPH MNMISNFIGS KNIEHDHQRF LNSDVEESKT FLNSPSFQNI DVIGTLLLVD
     VLIRYFTKQG YINEENDSAS DEGVQAAALE ITENFENFLN VFDDTPKEQV DLTEVHRKVY
     AALKSGRKSQ IHQVLCSSLK SVSKLEPAEI ETLVSELLNL QSSFPLTKFP PSTAEAFENS
     LHILGESCLN SEWSPSLMLM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024